Corcept's ovarian cancer combination drug meets main goal in late-stage study-February 2024-www.financetom.com

Corcept's ovarian cancer combination drug meets main goal in late-stage study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Corcept's ovarian cancer combination drug meets main goal in late-stage study

Mar 31, 2025 5:22 AM

March 31 (Reuters) - Corcept Therapeutics ( CORT ) said

on Monday its experimental ovarian cancer drug in combination

with chemotherapy met the main goal of a late-stage trial.

Previous page： Update: KKR Raises Offer for Fuji Soft to $63.45 a Share Next page： Vertical Aerospace Completes Phase 2 Piloted Thrustborne Testing of VX4 Prototype

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Update: KKR Raises Offer for Fuji Soft to $63.45 a Share

Feb 4, 2025

10:31 AM EST, 02/04/2025 (MT Newswires) -- (Updates to add details from KKR and change attributions throughout.) KKR (KKR) said Tuesday it has raised its offer for Fuji Soft to 9,850 Japanese yen ($63.45) per share, from 9,451 yen previously. The company said it extended the tender offer period to Feb. 19 from the previous Feb. 7 deadline. KKR said...

Vertical Aerospace Completes Phase 2 Piloted Thrustborne Testing of VX4 Prototype

Feb 4, 2025

10:30 AM EST, 02/04/2025 (MT Newswires) -- Vertical Aerospace ( EVTWF ) said Tuesday it completed phase 2 of piloted thrustborne testing of its VX4 prototype of a four-passenger electric vertical take-off and landing aircraft, paving the way for piloted wingborne testing. The company said the prototype flights didn't suffer any system failures and surpassed expectations for stability and performance....

Unisys, Chicago Quantum Exchange Collaborate on Quantum Technology Applications

Feb 4, 2025

10:35 AM EST, 02/04/2025 (MT Newswires) -- Unisys ( UIS ) said Tuesday it has formed a partnership with Chicago Quantum Exchange to drive industry-specific quantum technology applications. Chicago Quantum Exchange will give Unisys ( UIS ) access to quantum researchers and talent to mutually explore and develop quantum technology tools to help solve challenges faced by businesses, Unisys (...

Fiscalnote Regains Compliance With NYSE Minimum Bid Price Requirement for Continued Listing

Feb 4, 2025

10:30 AM EST, 02/04/2025 (MT Newswires) -- Fiscalnote ( NOTE ) said Tuesday it was informed Monday by the New York Stock Exchange that the company had regained compliance with the $1-per-share minimum share price requirement for continued listing on the exchange. The company's shares were up 4.7% in recent Tuesday trading. Price: 1.24, Change: +0.06, Percent Change: +4.66 ...